These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 27089522)

  • 1. Combining clinical variables to optimize prediction of antidepressant treatment outcomes.
    Iniesta R; Malki K; Maier W; Rietschel M; Mors O; Hauser J; Henigsberg N; Dernovsek MZ; Souery D; Stahl D; Dobson R; Aitchison KJ; Farmer A; Lewis CM; McGuffin P; Uher R
    J Psychiatr Res; 2016 Jul; 78():94-102. PubMed ID: 27089522
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antidepressant drug-specific prediction of depression treatment outcomes from genetic and clinical variables.
    Iniesta R; Hodgson K; Stahl D; Malki K; Maier W; Rietschel M; Mors O; Hauser J; Henigsberg N; Dernovsek MZ; Souery D; Dobson R; Aitchison KJ; Farmer A; McGuffin P; Lewis CM; Uher R
    Sci Rep; 2018 Apr; 8(1):5530. PubMed ID: 29615645
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of a Machine Learning Model Based on Pretreatment Symptoms and Electroencephalographic Features to Predict Outcomes of Antidepressant Treatment in Adults With Depression: A Prespecified Secondary Analysis of a Randomized Clinical Trial.
    Rajpurkar P; Yang J; Dass N; Vale V; Keller AS; Irvin J; Taylor Z; Basu S; Ng A; Williams LM
    JAMA Netw Open; 2020 Jun; 3(6):e206653. PubMed ID: 32568399
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Depression symptom dimensions as predictors of antidepressant treatment outcome: replicable evidence for interest-activity symptoms.
    Uher R; Perlis RH; Henigsberg N; Zobel A; Rietschel M; Mors O; Hauser J; Dernovsek MZ; Souery D; Bajs M; Maier W; Aitchison KJ; Farmer A; McGuffin P
    Psychol Med; 2012 May; 42(5):967-80. PubMed ID: 21929846
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Non-random dropout and the relative efficacy of escitalopram and nortriptyline in treating major depressive disorder.
    Power RA; Muthén B; Henigsberg N; Mors O; Placentino A; Mendlewicz J; Maier W; McGuffin P; Lewis CM; Uher R
    J Psychiatr Res; 2012 Oct; 46(10):1333-8. PubMed ID: 22770672
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An inflammatory biomarker as a differential predictor of outcome of depression treatment with escitalopram and nortriptyline.
    Uher R; Tansey KE; Dew T; Maier W; Mors O; Hauser J; Dernovsek MZ; Henigsberg N; Souery D; Farmer A; McGuffin P
    Am J Psychiatry; 2014 Dec; 171(12):1278-86. PubMed ID: 25017001
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Melancholic, atypical and anxious depression subtypes and outcome of treatment with escitalopram and nortriptyline.
    Uher R; Dernovsek MZ; Mors O; Hauser J; Souery D; Zobel A; Maier W; Henigsberg N; Kalember P; Rietschel M; Placentino A; Mendlewicz J; Aitchison KJ; McGuffin P; Farmer A
    J Affect Disord; 2011 Jul; 132(1-2):112-20. PubMed ID: 21411156
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparison of mirtazapine and nortriptyline following two consecutive failed medication treatments for depressed outpatients: a STAR*D report.
    Fava M; Rush AJ; Wisniewski SR; Nierenberg AA; Alpert JE; McGrath PJ; Thase ME; Warden D; Biggs M; Luther JF; Niederehe G; Ritz L; Trivedi MH
    Am J Psychiatry; 2006 Jul; 163(7):1161-72. PubMed ID: 16816220
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential change on depressive symptom factors with antidepressant medication and cognitive behavior therapy for major depressive disorder.
    Dunlop BW; Cole SP; Nemeroff CB; Mayberg HS; Craighead WE
    J Affect Disord; 2018 Mar; 229():111-119. PubMed ID: 29306690
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Body weight as a predictor of antidepressant efficacy in the GENDEP project.
    Uher R; Mors O; Hauser J; Rietschel M; Maier W; Kozel D; Henigsberg N; Souery D; Placentino A; Perroud N; Dernovsek MZ; Strohmaier J; Larsen ER; Zobel A; Leszczynska-Rodziewicz A; Kalember P; Pedrini L; Linotte S; Gunasinghe C; Aitchison KJ; McGuffin P; Farmer A
    J Affect Disord; 2009 Nov; 118(1-3):147-54. PubMed ID: 19269691
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cross-trial prediction of treatment outcome in depression: a machine learning approach.
    Chekroud AM; Zotti RJ; Shehzad Z; Gueorguieva R; Johnson MK; Trivedi MH; Cannon TD; Krystal JH; Corlett PR
    Lancet Psychiatry; 2016 Mar; 3(3):243-50. PubMed ID: 26803397
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Variation in GNB3 predicts response and adverse reactions to antidepressants.
    Keers R; Bonvicini C; Scassellati C; Uher R; Placentino A; Giovannini C; Rietschel M; Henigsberg N; Kozel D; Mors O; Maier W; Hauser J; Souery D; Mendlewicz J; Schmäl C; Zobel A; Larsen ER; Szczepankiewicz A; Kovacic Z; Elkin A; Craig I; McGuffin P; Farmer AE; Aitchison KJ; Gennarelli M
    J Psychopharmacol; 2011 Jul; 25(7):867-74. PubMed ID: 20826553
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictive socioeconomic and clinical profiles of antidepressant response and remission.
    Jain FA; Hunter AM; Brooks JO; Leuchter AF
    Depress Anxiety; 2013 Jul; 30(7):624-30. PubMed ID: 23288666
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of antidepressant switching between nortriptyline and escitalopram after a failed first antidepressant treatment among patients with major depressive disorder.
    Köhler-Forsberg O; Larsen ER; Buttenschøn HN; Rietschel M; Hauser J; Souery D; Maier W; Farmer A; McGuffin P; Aitchison KJ; Uher R; Mors O
    Br J Psychiatry; 2019 Aug; 215(2):494-501. PubMed ID: 30698114
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heart rate variability as a biomarker of anxious depression response to antidepressant medication.
    Kircanski K; Williams LM; Gotlib IH
    Depress Anxiety; 2019 Jan; 36(1):63-71. PubMed ID: 30311742
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DNA methylation in interleukin-11 predicts clinical response to antidepressants in GENDEP.
    Powell TR; Smith RG; Hackinger S; Schalkwyk LC; Uher R; McGuffin P; Mill J; Tansey KE
    Transl Psychiatry; 2013 Sep; 3(9):e300. PubMed ID: 24002086
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genome-wide pharmacogenetics of antidepressant response in the GENDEP project.
    Uher R; Perroud N; Ng MY; Hauser J; Henigsberg N; Maier W; Mors O; Placentino A; Rietschel M; Souery D; Zagar T; Czerski PM; Jerman B; Larsen ER; Schulze TG; Zobel A; Cohen-Woods S; Pirlo K; Butler AW; Muglia P; Barnes MR; Lathrop M; Farmer A; Breen G; Aitchison KJ; Craig I; Lewis CM; McGuffin P
    Am J Psychiatry; 2010 May; 167(5):555-64. PubMed ID: 20360315
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early and delayed onset of response to antidepressants in individual trajectories of change during treatment of major depression: a secondary analysis of data from the Genome-Based Therapeutic Drugs for Depression (GENDEP) study.
    Uher R; Mors O; Rietschel M; Rajewska-Rager A; Petrovic A; Zobel A; Henigsberg N; Mendlewicz J; Aitchison KJ; Farmer A; McGuffin P
    J Clin Psychiatry; 2011 Nov; 72(11):1478-84. PubMed ID: 22127194
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterising anxiety in major depressive disorder and its use in predicting antidepressant treatment outcome: An iSPOT-D report.
    Braund TA; Palmer DM; Williams LM; Harris AW
    Aust N Z J Psychiatry; 2019 Aug; 53(8):782-793. PubMed ID: 30880405
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antidepressant effects of nortriptyline and escitalopram in the GENDEP study: is one better than the other?
    Uher R; Mors O; McGuffin P
    Acta Psychiatr Scand; 2013 Apr; 127(4):330. PubMed ID: 23480387
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.